IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Enliven Therapeutics Inc

CUSIP: 29337E106 | 3 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2026

Covestor Ltd2,007
0.0% of portfolio›$70
StyleTurnoverLocationFiled
Covestor Ltd
2,007$700.0%ValueHighLondon, United Kingdom2026-10-30